I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 26% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 26% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 16% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 832.67 | 2642 / 2642 | 100% | 6.67 | 705 / 705 |
| prostate | 100% | 1211.96 | 245 / 245 | 100% | 6.35 | 502 / 502 |
| thymus | 100% | 1399.72 | 653 / 653 | 100% | 7.05 | 605 / 605 |
| kidney | 100% | 1119.03 | 89 / 89 | 99% | 5.92 | 895 / 901 |
| breast | 100% | 1116.42 | 459 / 459 | 99% | 7.37 | 1109 / 1118 |
| pancreas | 100% | 584.69 | 327 / 328 | 99% | 3.86 | 177 / 178 |
| ovary | 100% | 1260.86 | 180 / 180 | 99% | 4.16 | 425 / 430 |
| adrenal gland | 100% | 1263.02 | 258 / 258 | 99% | 4.92 | 227 / 230 |
| bladder | 100% | 1252.14 | 21 / 21 | 98% | 4.30 | 493 / 504 |
| lung | 98% | 758.13 | 566 / 578 | 97% | 4.54 | 1125 / 1155 |
| stomach | 100% | 790.41 | 359 / 359 | 95% | 3.67 | 271 / 286 |
| liver | 100% | 688.74 | 226 / 226 | 95% | 3.05 | 384 / 406 |
| esophagus | 100% | 975.89 | 1445 / 1445 | 95% | 4.85 | 173 / 183 |
| intestine | 100% | 993.93 | 966 / 966 | 93% | 3.49 | 492 / 527 |
| skin | 100% | 987.81 | 1805 / 1809 | 91% | 4.02 | 430 / 472 |
| uterus | 100% | 1152.12 | 170 / 170 | 91% | 4.36 | 417 / 459 |
| adipose | 100% | 920.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 3.42 | 29 / 29 |
| spleen | 100% | 934.51 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.38 | 1 / 1 |
| blood vessel | 100% | 874.61 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 529.29 | 842 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 4.65 | 44 / 45 |
| muscle | 91% | 317.66 | 728 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 76% | 2.54 | 61 / 80 |
| peripheral blood | 47% | 340.03 | 437 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0045597 | Biological process | positive regulation of cell differentiation |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0030335 | Biological process | positive regulation of cell migration |
| GO_0030154 | Biological process | cell differentiation |
| GO_0007346 | Biological process | regulation of mitotic cell cycle |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_0051726 | Biological process | regulation of cell cycle |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF268 |
| Protein name | ZNF268 protein Zinc finger protein 268 (Zinc finger protein HZF3) Zinc finger protein 268 |
| Synonyms | |
| Description | FUNCTION: [Isoform 1]: Acts as a transcriptional repressor. Inhibits erythroid differentiation and tumor cell proliferation. Plays a role during ovarian cancer development and progression.; FUNCTION: [Isoform 2]: Contributes to cervical carcinogenesis in part through the TNF-alpha-induced NF-kappa-B signaling pathway by interacting with the I-kappa-B-kinase (IKK) core complex. FUNCTION: May be involved in transcriptional regulation. . |
| Accessions | ENST00000542711.6 F5H6R9 ENST00000500625.7 K7EQP6 ENST00000541975.2 ENST00000542986.6 K7EIF0 ENST00000228289.9 [Q14587-1] F5H1T2 F5H7L3 ENST00000592241.5 ENST00000539248.6 [Q14587-6] F5H670 A0A075B6T9 ENST00000611984.4 F5H467 Q14587 K7EMS6 Q2TB61 ENST00000588312.2 [Q14587-7] ENST00000541009.6 ENST00000546126.7 ENST00000536899.6 ENST00000591951.1 ENST00000536435.7 [Q14587-1] A0A087WV54 E7EV44 F5H848 ENST00000541211.6 ENST00000416488.5 |
